GLP-1 (glucagon-like peptide-1) is a naturally occurring incretin hormone secreted by enteroendocrine L-cells in the small intestine in response to food intake, where it signals satiety to the brain through hypothalamic receptor binding, slows gastric emptying to prolong the feeling of fullness, and modulates the release of insulin and glucagon in a glucose-dependent manner that helps stabilize post-meal blood sugar without the hypoglycemia risk associated with older drug classes
Schloot, et al., 'Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial', Lancet Diabetes Endocrinol
STEP 1 trial extension studies the changes in body weights and cardiometabolic risk factors after Wegovy discontinuation
Whether youre seeking a gentle boost or a medical adjunct to your weight loss efforts, our B12 shot treatments are a popular and safe option
These accounts underscore the need for open communication with medical professionals to address concerns and ensure comprehensive care
No Proceed to question 6